Euroapi: stock up as broker raises TP
(CercleFinance.com) - On Tuesday Deutsche Bank raised its target price for Euroapi shares from 20 euros to 22 euros, while maintaining its buy rating on them.
The broker, which welcomes the better-than-expected interim results published by the active pharmaceutical ingredients manufacturer, says that it believes that the group's investment record has recently improved.
In its comments, the analyst mentions a number of features that could appeal to investors, starting with a business model and end markets that remain "robust" - despite the economic downturn.
It points to continued strong demand, from both its parent company Sanofi and active pharmaceutical ingredient development and manufacturing (APDM) services.
The share is currently up 4% on these comments.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The broker, which welcomes the better-than-expected interim results published by the active pharmaceutical ingredients manufacturer, says that it believes that the group's investment record has recently improved.
In its comments, the analyst mentions a number of features that could appeal to investors, starting with a business model and end markets that remain "robust" - despite the economic downturn.
It points to continued strong demand, from both its parent company Sanofi and active pharmaceutical ingredient development and manufacturing (APDM) services.
The share is currently up 4% on these comments.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.